BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB)

Historical Holders from Q4 2020 to Q3 2025

Symbol
BCAB on Nasdaq
CUSIP
09077B104
Type / Class
Equity / Common Stocks, par value $0,0001 per share
Shares outstanding
58.5M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
13.3M
Holdings value
$9.14M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
41
Number of buys
19
Number of sells
-11
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
HIGHBRIDGE CAPITAL MANAGEMENT LLC 7.7% -22% $1.31M -$678K 4.84M -34.1% Highbridge Capital Management, LLC Mar 31, 2025
ACORN BIOVENTURES, L.P. 8.3% $2.13M 4.84M Anders Hove May 15, 2025
SHORT JAY M PHD 6.6% $1.04M 3.87M Jay M. Short Dec 31, 2024
OPOKA INVESTMENT FUND Co 4.8% -21.7% $1.93M -$507K 2.81M -20.8% OPOKA INVESTMENT FUND Co Jul 9, 2025
MILLENNIUM MANAGEMENT LLC 1.9% $296K 1.1M Millennium Management LLC Dec 31, 2024

Institutional Holders of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 13.3M $9.14M +$217K $0.69 41
2025 Q2 13.2M $5.21M -$178K $0.40 39
2025 Q1 13.7M $4.76M -$6.04M $0.35 40
2024 Q4 24M $14.2M -$3.75M $0.59 66
2024 Q3 17.3M $30.4M -$6.87M $1.76 62
2024 Q2 22.1M $30.4M -$9.19M $1.37 78
2024 Q1 24.9M $85.5M -$4.27M $3.44 83
2023 Q4 17.9K $43.9K $2.46 1
2023 Q3 29.4M $50M -$3.98M $1.70 79
2023 Q2 31.5M $94.5M -$2.35M $3.00 84
2023 Q1 32.8M $87.6M -$35.8M $2.68 78
2022 Q4 33.8M $279M +$75.6M $8.25 87
2022 Q3 23M $177M +$12.4M $7.70 65
2022 Q2 23.5M $66.9M -$8.83M $2.85 70
2022 Q1 25.5M $128M -$39.6M $5.00 90
2021 Q4 25.7M $505M +$1.2M $19.63 77
2021 Q3 25.3M $746M +$120M $29.44 81
2021 Q2 21.2M $897M +$89.2M $42.38 74
2021 Q1 19M $965M +$188M $50.84 62
2020 Q4 15.7M $530M +$530M $34.01 53